Anebulo Pharmaceuticals, Inc. financial statements
Anebulo Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 8.48M | 10-K |
| Cash and equivalents | USD 11.63M | 10-Q |
Anebulo Pharmaceuticals, Inc. financials on 6ix · Anebulo Pharmaceuticals, Inc. on 6ix